Article: HIV-1 Immunogen Induces Allo- And HIV Specific Immune Responses.(Brief Article)

2001 JUL 2 - (NewsRx.com & NewsRx.net) --

The Immune Response Corporation (Nasdaq:IMNR) announced interim clinical results from an ongoing Phase II trial, indicating that treatment with Remune (HIV-1 Immunogen), an investigational product, appears to induce both allo- and HIV specific cell-mediated immune responses.

The data were presented at the Federation of Clinical Immunology Societies (FOCIS) first annual meeting in Boston, Massachusetts, May 4-7, 2001.

Research has shown that allo (allo-geneic) immune responses are directed to human leukocyte antigens (HLA) and are associated with development of both CD4(+) T helper and CD8(+) cytotoxic ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!